RetiSpec

Tel Aviv, Israel Founded: 2015 • Age: 11 yrs
Non-invasive eye scanner for early Alzheimers detection is developed.
Request Access

About RetiSpec

RetiSpec is a company based in Tel Aviv (Israel) founded in 2015.. RetiSpec has raised $10 million across 3 funding rounds from investors including Lilly, Gentex and University of Minnesota. RetiSpec offers products and services including Hyperspectral Imaging Technology and Retinal Scanner. RetiSpec operates in a competitive market with competitors including Tobii Dynavox, Inscopix, Neurotrack, Brainomix and Artiria, among others.

  • Headquarter Tel Aviv, Israel
  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Retispec Inc
Operational Areas
Healthcare → Health Technology & Digital Health
Technology → Artificial Intelligence & Machine Learning
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $10 M (USD)

    in 3 rounds

  • Latest Funding Round
    $10 M (USD), Series A

    Jul 26, 2024

  • Investors
    Lilly

    & 8 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of RetiSpec

RetiSpec offers a comprehensive portfolio of products and services, including Hyperspectral Imaging Technology and Retinal Scanner. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

AI-based system for detecting Alzheimer's via retinal scans.

Non-invasive tool for early identification of brain amyloid build-up.

People of RetiSpec
Headcount 10-50
Employee Profiles 12
Board Members and Advisors 3
Employee Profiles
People
Mailis Bietenhader
Opthomaltic Photographer
People
Nir Oren
Senior Software Engineer
People
Jennifer Giordano
Manager of Clinical Operations
People
Roy Kirshon
COO & Co-Founder

Unlock access to complete

Board Members and Advisors
people
Iman Jeddi
Director
people
Sam Ifergan
Director
people
Robert Vance
VP, New Markets, Gentex Corporation

Unlock access to complete

Funding Insights of RetiSpec

RetiSpec has successfully raised a total of $10M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series A — $10.0M
  • First Round

    (21 Jun 2017)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2024 Amount Series A - RetiSpec Valuation iGan Partners
Oct, 2019 Amount Grant - RetiSpec Valuation

investors

Jun, 2017 Amount Grant - RetiSpec Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in RetiSpec

RetiSpec has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Lilly, Gentex and University of Minnesota. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Healthcare-focused venture capital is provided by iGan Partners.
Founded Year Domain Location
Brain research and care innovation is driven in Ontario.
Founded Year Domain Location
Innovation in aging and brain health is driven by CABHI.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by RetiSpec

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - RetiSpec

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Retispec Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of RetiSpec

RetiSpec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tobii Dynavox, Inscopix, Neurotrack, Brainomix and Artiria, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Assistive communication solutions via eye-tracking are provided for differently-abled individuals.
domain founded_year HQ Location
Miniscope platforms are developed for decoding brain neural circuits.
domain founded_year HQ Location
Neurological disorders are diagnosed using eye-tracking assessment tools.
domain founded_year HQ Location
AI-powered imaging biomarkers are provided for precision medicine applications.
domain founded_year HQ Location
Micro-navigation systems for stroke surgery are developed.
domain founded_year HQ Location
Brain monitoring devices and analytics platforms are developed and provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Retispec

Frequently Asked Questions about RetiSpec

When was RetiSpec founded?

RetiSpec was founded in 2015 and raised its 1st funding round 2 years after it was founded.

Where is RetiSpec located?

RetiSpec is headquartered in Tel Aviv, Israel.

Is RetiSpec a funded company?

RetiSpec is a funded company, having raised a total of $10M across 3 funding rounds to date. The company's 1st funding round was a Grant of $50K, raised on Jun 21, 2017.

What does RetiSpec do?

RetiSpec was an early stage medical device startup developing a non-invasive eye scanner for early detection of Alzheimers Disease. The company was selected as the finalists at the MassChallenge Boston accelerator had won 1st place at the JNF Lions-Den competition in Toronto at the 2016 Partners Connected Health and AARP startup competition in Boston. As of Jan 2017, the company hasnt disclosed its product development details.

Who are the top competitors of RetiSpec?

RetiSpec's top competitors include NovaSight, CND Life Sciences and NeuroKaire.

What products or services does RetiSpec offer?

RetiSpec offers Hyperspectral Imaging Technology and Retinal Scanner.

Who are RetiSpec's investors?

RetiSpec has 9 investors. Key investors include Lilly, Gentex, University of Minnesota, Alzheimer's Drug Discovery, and iGan Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available